Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is an strategic research organization which is engaged on advancing therapies and accelerating drug development. The company conducts community based clinical trials in cardiology, oncology, gastroenterologyz and other therapeutic areas through affiliations with a network of over 450 physicians in 25 states. It also provides research support services to its pharmaceutical and biotechnology partners that include data management, project management, monitoring, regulatory, site qualification, safety, medical writing, quality assurance, scientific analysis, contracting and budget services and site payments. The company entered into a merger and acquired Summit Research Solutions. SCRI operates through its subsidiary SCRI Services Inc. Sarah Cannon Research Instituteis headquartered in Nashville, the US. Sarah Cannon Research Institute to Present Trial Findings on Treatments for Esophageal and Colorectal Cancer.

Street: 
3322 West End Avenue
City: 
Nashville
Postcode: 
37203
Federal State : 
United States
WebSite: 
www.sarahcannonresearch.com

Company Index Score

Current Index Score Historical Index Score
  • Sarah Cannon Research Institute currently scores 50 % in the index.
  • Sarah Cannon Research Institute is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Sarah Cannon Research Institute is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets